DEADLINE MONDAY ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Bayer Aktiengesellschaft and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 09/11/20
Bayer: Supervisory Board Extends CEO Werner Baumann’s Contract Until the End of April 2024Business Wire • 09/10/20
BAYRY DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Bayer Aktiengesellschaft Shareholders With Losses Exceeding $2 Million of Class Action and Lead Plaintiff Deadline: September 14, 2020Business Wire • 09/10/20
MONDAY DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Bayer Aktiengesellschaft and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 09/10/20
MONDAY DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Bayer Aktiengesellschaft and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 09/09/20
Bayer Collaborates with Recursion to Strengthen Digital Drug Discovery and Advance New Therapies for Fibrotic DiseasesBusiness Wire • 09/09/20
Bayer Completes Acquisition of the UK-based Biotech Company KaNDy Therapeutics Ltd.Business Wire • 09/09/20
Bayer Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $500,000 In Bayer Aktiengesellschaft To Contact The FirmNewsfile Corp • 09/08/20
MONDAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Bayer Aktiengesellschaft and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 09/08/20
Bayer to Showcase New Data from Evolving Oncology Portfolio at ESMO Virtual Congress 2020Business Wire • 09/08/20
Bayer Phase IV Study Met its Primary Endpoint in PAH Patients Who Had Transitioned to Adempas® (riociguat) After Insufficient Response to PDE5 InhibitorsBusiness Wire • 09/07/20
ROSEN, NATIONAL TRIAL LAWYERS, Reminds Bayer Aktiengesellschaft Investors of Important Deadline in Securities Class Action - BAYRY, BAYZFNewsfile Corp • 09/04/20
ROSEN, A GLOBAL AND LEADING LAW FIRM, Reminds Bayer Aktiengesellschaft Investors of Important Deadline in Securities Class Action - BAYRY, BAYZFPRNewsWire • 08/28/20
Bayer and Northpond Ventures Lead USD $55 Million Series A Financing Round for Triumvira ImmunologicsBusiness Wire • 08/27/20
ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Reminds Bayer Aktiengesellschaft Investors of Important Deadline in Securities Class Action - BAYRY, BAYZFPRNewsWire • 08/15/20